Old Web
English
Sign In
Acemap
>
authorDetail
>
Amir Handzel
Amir Handzel
AstraZeneca
Savolitinib
Pathology
Medicine
Gefitinib
Mutant
5
Papers
134
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OA 09.06 A Phase Ib Trial of Savolitinib plus Gefitinib for Chinese Patients with EGFR-Mutant MET-Amplified Advanced NSCLC
2017
Journal of Thoracic Oncology
J. Yang
J Fang
Yongqian Shu
Jianhua Chang
G. Chen
Jiaxi He
Wei Li
X. Liu
N. Yang
C. Zhou
Jin Huang
Ling Yang
Amir Handzel
Melanie M. Frigault
G. Ahmed
C. Egile
Shethah Morgan
Yi-Long Wu
Show All
Source
Cite
Save
Citations (15)
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer
2017
Journal of Clinical Oncology
Toni K. Choueiri
Elizabeth R. Plimack
Hendrik-Tobias Arkenau
Eric Jonasch
Daniel Y.C. Heng
Thomas Powles
Melanie M. Frigault
Edwin Clark
Amir Handzel
Humphrey Gardner
Shethah Morgan
Laurence Albiges
Sumanta K. Pal
Show All
Source
Cite
Save
Citations (107)
A single-arm biomarker-based phase II trial of savolitinib in patients with advanced papillary renal cell cancer (PRCC).
2017
Journal of Clinical Oncology
Toni K. Choueiri
Elizabeth R. Plimack
Hendrik-Tobias Arkenau
Eric Jonasch
Daniel Yick Chin Heng
Thomas Powles
Melanie M. Frigault
Edwin A. Clark
Amir Handzel
Humphrey Gardner
Shethah Morgan
Laurence Albiges
Sumanta K. Pal
Show All
Source
Cite
Save
Citations (9)
Preliminary results of a phase Ib trial of savolitinib combined with gefitinib in EGFR-mutant lung cancer.
2016
Journal of Clinical Oncology
Jin-ji Yang
Liu Yang
Andrew Farnsworth
Amir Handzel
Tanya Coleman
Shethah Morgan
Yi-Long Wu
Show All
Source
Cite
Save
Citations (3)
The Geometry of Eye Rotations and Listing's Law
1995
| Annual Conference on Neural Information Processing Systems
Amir Handzel
Tamar Flash
Show All
Source
Cite
Save
Citations (0)
1